NCT04205266View on ClinicalTrials.gov

IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding

PHASE4RecruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

February 14, 2020

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Anemia, Iron DeficiencyHeavy Menstrual Bleeding
Interventions
DRUG

Ferumoxytol

IV iron infusion

DRUG

Ferrous Sulfate

oral iron therapy

Trial Locations (1)

19107

RECRUITING

Thomas Jefferson University, Philadelphia

Sponsors
All Listed Sponsors
collaborator

AMAG Pharmaceuticals, Inc.

INDUSTRY

lead

Thomas Jefferson University

OTHER